Apr 14, 2022 6:45pm EDT LIXTE Biotechnology Announces the Closing of $5.8 Million Registered Direct Offering Priced At-The-Market
Apr 12, 2022 1:52pm EDT LIXTE Biotechnology Announces $5.8 Million Registered Direct Offering Priced At-The-Market
